GALWAY, Ireland--(BUSINESS WIRE)--Vivasure Medical (Vivasure) is pleased to announce the successful enrollment of the first patient in the Frontier IV clinical study, a non-randomized multicenter international trial, designed to expand…
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x430-stock-positive.jpg" NAME"Ardelyx Shares Soared After Positive Phase III Results for Tenapanor" ALT"Ardelyx Shares Soared After Positive Phase III Results for Tenapanor"October 12, 2017By Alex Keown, BioSpace.com Breaking... Source: BioSpace
BEDFORD, Mass.--(BUSINESS WIRE)--Anika ... Source: BioSpace
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-merck.jpg" NAME"Merck Scraps Experimental Cholesterol Drug Anacetrapib" ALT"Merck Scraps Experimental Cholesterol Drug Anacetrapib"October 12, 2017By Mark Terry, BioSpace.com Breaking News StaffKenilworth, NJ... Source: BioSpace
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Wave Life Sciences Ltd. (NASDAQ:WVE), a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined diseases, today announced that Paul Bolno, M.D., MBA, President and…
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x430-axovant-david-hung.jpg" NAME"Heres the Best Career Advice from Axovant's CEO" ALT"Heres the Best Career Advice from Axovant's CEO"October 12, 2017By Mark Terry, BioSpace.com Breaking News StaffWant career advice... Source: BioSpace
SAN DIEGO, Oct. 12, 2017 /PRNewswire/ --<img src"https://mma.prnewswire.com/media/582279/Johnson_and_Johnson_Innovation_LLC___JLABS.jpg" title"Johnson & Johnson Innovation, JLABS (PRNewsFoto/Johnson & Johnson Innovation, LL)" alt... Source: BioSpace
Life Sciences Jobs ... Source: BioSpace
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-fda.jpg" NAME"AcelRx Stopped Cold: FDA Rejects NDA for Pain Drug Dsuvia (ARX-04)" ALT"AcelRx Stopped Cold: FDA Rejects NDA for Pain Drug Dsuvia (ARX-04)"October 12, 2017By Alex Keown, BioSpace.com Breaking…
BOSTON--(BUSINESS WIRE)--Cerevance, a drug discovery and development company focused on brain diseases, today announced that Rudolph Tanzi, Ph.D., has joined the company as a senior-level scientific advisor. Dr. Tanzi is…